• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Making of flu vaccine a regimented process

cozodapo

Resident
Good layperson's (no pun intended) introduction to manufacturing flu vaccines...

From: http://www.signonsandiego.com/uniontrib/20041024/news_1n24flu.html

HEALTH
Making of flu vaccine a regimented process

Production can't be rushed due to dependence on eggs
By Marilynn Marchione
ASSOCIATED PRESS
October 24, 2004
SWIFTWATER, Pa. – As the nation struggles with a historic shortage of flu vaccine, the last batches of this year's supply are being bottled at a slickly run, modern factory in the Pocono Mountains.
A little to the west, in Amish country, next year's doses are already in the works. At the moment, they have two legs and soft, downy feathers. By January, they'll be laying millions of eggs for flu shots.
There is far more horse-and-buggy to vaccine production than just the Amish wagons that creak past Pennsylvania chicken farms.
This quaint system based on seasonal egg-laying has harsh implications for what would happen if a new vaccine had to be made in a hurry to fight a super-strain flu pandemic. At best, it would take half a year.
And since chicken flocks for next year's vaccine are already established and plants already run at full capacity, it's unclear how much Aventis Pasteur or any single company can goose up production to cover a shortfall like this year's loss of Chiron Corp.'s vaccine.
As Chiron executive Dr. Kevin Bryett said in an interview two weeks before its British factory was shut down: "If the market was to change dramatically, it is almost impossible to turn up production. The primary issue is access to the eggs. Large numbers of birds cannot be obtained immediately. It's not something you can just go down to the shop and buy, eggs off the shelf."
A visit to Aventis, America's only flu-shot maker, reveals how much fragile Americans depend on an eggshell-fragile system to protect them from a killer disease. The Associated Press was allowed inside last week for a rare, firsthand look.
Vaccines are biological products, not chemicals that can be cranked out in times of need.
The viruses they're made from need cells in which to grow. Yellow fever and flu are the only vaccines that use eggs for this – not the kind that come from the store but those produced under strict pharmaceutical conditions.
Flu also is the only vaccine made fresh every year. In late February or early March, the World Health Organization picks its three strains based on the virus going around. If it acts too soon, newly emerging strains can be missed, as Fujian was last year.
If it waits too long, vaccine makers must race against the biological clocks of hens, which only lay eggs for nine months until they're too old, then rush through a several-months-long process to make enough vaccine before the flu season starts.
"We're constrained on the front end and the back end. No other vaccine has that kind of time pressure," said Aventis spokesman Len Lavenda.
Dr. Anthony Fauci, the government's top vaccine scientist, acknowledged the difficulty.
"The ability to have surge capacity when something goes wrong, to turn on a dime and try and correct it, is difficult," he said in an interview Thursday.
Aventis starts making vaccine more than a year in advance, around August on nearly 50 farms throughout Pennsylvania.
"They're fairly small operations," many with only 10,000 birds, said Sam Lee, a 40-year-old chemical engineer who is the company's operations team leader.
White leghorn hens are used. The exact type is a company secret. The breeder holding the patent supplies the eggs, which take 21 days to hatch and become chicks.
They're moved in late September into buildings where they can move freely as opposed to cages and coops, and spend three months maturing into hens.
Egg-laying starts in late December, typically one a day. How many eggs it takes to make a flu shot is another Aventis secret, but Chiron's Bryett said: "If you're very lucky, you'll get three doses per egg." That's for a single flu strain; three strains go into each dose of vaccine.
The fertilized eggs are collected by two large egg producers, who incubate them for seven to 12 days and then bring them to Aventis. Eggs delivered in January would hatch into chicks if not used for vaccine, so manufacturers often gamble and start making whichever of the three flu strains WHO seems most likely to choose.
"Any production before February is done at the company's risk," Lee said.
A machine punches a tiny hole in each shell and a needle inoculates the chick embryo with a single flu strain. The virus is allowed to multiply for about three days.
Then the eggs are broken, and the fluid around the embryo containing the virus is collected and purified. Formaldehyde is added to inactivate the flu virus, and a machine spins the mixture to separate out the part containing virus.
Once again, eggs are needed: A sample of the spun solution is put back in the eggs to see if any virus grows – a test to ensure the germ was inactivated. A few more processing steps turn it into a lot, or batch, of several hundred thousand doses of a single strain.
Next comes sterility testing where vaccine is spread onto lab dishes and checked to see if it contains contaminating bacteria.
"We haven't had a contamination in years," Lee said.
It's not known whether this step is where Chiron's vaccine was discovered to be tainted with serratia bacteria or if it happened later.
As Aventis tests for sterility, samples also go to the Food and Drug Administration, which doesn't start its testing until late May or early June because it has to brew specific chemicals each year to test specific strains.
After that, three viral strains are combined to form the trivalent vaccine. Four weeks of potency and sterility testing follow, then packaging into single-dose syringes and 10-dose vials and quality checks for potency.
The last doses are made by the end of September. Chicken farms are free to sell old birds and must do a mandatory cleanout and disinfection to get ready to start the whole process all over again.
As cumbersome as this egg-based vaccine recipe may seem, "it has been over the years a reliable, time-tested and reasonably efficient way to get virus grown," Fauci said.
 
Back
Top